Pathobiology of malignant melanoma
Pathobiology of malignant melanoma
复制标题
恶性黑色素瘤的病理学
DOI：
--
复制
发表时间：
1987
期刊：
影响因子：
--
通讯作者：
D. Elder
中科院分区：
文献类型：
--
作者：
D. Elder
关于恶性黑色素瘤的书籍层出不穷，既反映了这个问题的严重性，也反映了正在取得的巨大进展。大卫·埃尔德（David Elder）整理的这本紧凑、组织良好的小书无疑是对该领域的有益贡献。来自费城埃尔德博士小组的医生，以及来自世界各地主要黑色素瘤研究中心的医生，已经贡献了11个非常有用的章节，涉及临床、组织病理学和流行病学问题。埃尔德博士为多作者评论卷的编辑取得了一些独特的成就；他写了一本书，内容连贯，风格相似，很少有不必要的重复。我不知道他是否只是很好地指导了他的作者，或者他是否真的编辑了他们的作品，但无论如何，结果都是令人愉快的。也许最杰出的三个章节是由Eider博士和他的长期同事Wallace H. Clark, Jr., m.d.撰写的关于恶性黑色素瘤的发育生物学和恶性黑色素瘤的肿瘤进展和预后的章节，以及Elder博士单独撰写的关于转移性黑色素瘤的章节。我发现另一个特别有价值的部分是Sagebiel博士关于黑色素瘤微分期的实践方面，以及对这种肿瘤的实验室解释的非常具体的建议。另一个令我高兴的章节是杜邦·盖里四世，医学博士写的，关于恶性黑色素瘤死亡率的控制，涉及到各种关于恶性黑色素瘤的公共教育。由于我参与了新墨西哥州黑色素瘤登记处，并有机会观察杰克·雷德曼博士的新墨西哥黑色素瘤项目，看到这些活动以及全球各地的类似活动被更多的科学文章所认可，对我来说是有益的。很明显，这本书中的所有材料都以一种或另一种形式在其他地方出版过，但是，与它的大多数竞争书相比，我认为你必须广泛地寻找关于恶性黑色素瘤最热门话题的最新文章。因此，我强烈推荐《恶性黑色素瘤病理生物学》。当然，这本薄薄的书96.75美元的价格会让很多人望而却步。然而，正如我对瑞士手表和瑞士军刀的价格变得理性一样，我想我现在也需要对瑞士医学书籍的价格变得理性。所有对恶性黑色素瘤感兴趣的医生都可以使用这一杰作，无论费用如何。我们应该对埃尔德博士和他的同事们表示感谢。
There is a never-ending flow of books dealing with malignant melanoma, reflecting both the serious nature of this problem and the immense progress being made. This compact, well-organized little volume put together by David Elder is certainly a helpful contribution to the field. Physicians from Dr. Elder's group in Philadelphia, as well as from major melanoma research centers around the world, have contributed 11 very useful chapters dealing with clinical, histopathologic, and epidemiologic problems. Dr. Elder has achieved something unique for editors of multiauthor review volumes; he has put together a book that has cohesion, similarity of style, and very little needless repetition. I do not know if he simply guided his authors well or if he actually edited their work, but in any event the result is pleasing. Perhaps the three most outstanding chapters are those by Dr. Eider and his longtime coworker, Wallace H. Clark, Jr., M.D., on the developmental biology of malignant melanoma and on tumor progression and prognosis in malignant melanoma, as well as the chapter by Dr. Elder alone on metastatic melanoma. Another section that I found particularly valuable was that by Dr. Sagebiel on the practical aspects of melanoma microstaging with very specific recommendations for laboratory interpretation of this tumor. Another chapter that pleased me was that by DuPont Guerry IV, M.D., on control of mortality from malignant melanoma, which dealt with the various public education efforts on malignant melanoma. Since I am involved with the New Mexico Melanoma Registry and have had a chance to observe Dr. Jack Redman's New Mexico Melanoma Project, it was rewarding to me to see these activities as well as similar ones around the globe recognized amidst more scientific articles. Clear/y, all of the material in this book has been published in one form or another elsewhere, but, in contrast to most of its competitor volumes, I think you would have to look far and wide to obtain so many up-to-date articles on the hottest topics of malignant melanoma. For this reason, I strongly recommend Pathobiology of Malignant Melanoma. The price of $96.75 for such a thin book will, of course, discourage many. However, just as I have become philosophic about the price of Swiss watches and Swiss army knives, I guess I now need to become philosophic about the price of Swiss medical books. This masterpiece should be available to all physicians interested in malignant melanoma, regardless of cost. We owe a vote of thanks to Dr. Elder and his fellow authors.